These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3321314)

  • 1. Practical aspects in data monitoring: a brief review.
    Demets DL
    Stat Med; 1987; 6(7):753-60. PubMed ID: 3321314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interim analysis in therapeutic trials: a brief survey of current developments].
    Falissard B; Lellouch J
    Rev Epidemiol Sante Publique; 1991; 39(4):365-72. PubMed ID: 1754702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim analysis in clinical trials.
    Armitage P
    Stat Med; 1991 Jun; 10(6):925-35; discussion 936-7. PubMed ID: 1876782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data monitoring in clinical trials: the case for stochastic curtailment.
    Davis BR; Hardy RJ
    J Clin Epidemiol; 1994 Sep; 47(9):1033-42. PubMed ID: 7730906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim analysis: the alpha spending function approach.
    DeMets DL; Lan KK
    Stat Med; 1994 Jul 15-30; 13(13-14):1341-52; discussion 1353-6. PubMed ID: 7973215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Bayesian with group sequential methods for monitoring clinical trials.
    Armitage P
    Control Clin Trials; 1991 Apr; 12(2):345-50. PubMed ID: 1645645
    [No Abstract]   [Full Text] [Related]  

  • 11. A general formulation for a one-sided group sequential design.
    Moser BK; George SL
    Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential monitoring of clinical trials: the role of information and Brownian motion.
    Lan KK; Zucker DM
    Stat Med; 1993 Apr; 12(8):753-65. PubMed ID: 8516592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of clinical trials. Methodology, interim analyses, and end results].
    Pritsch M; Unnebrink K
    Med Klin (Munich); 1999 Dec; 94(12):712-7. PubMed ID: 10641517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic curtailment of health questionnaires: a method to reduce respondent burden.
    Finkelman MD; He Y; Kim W; Lai AM
    Stat Med; 2011 Jul; 30(16):1989-2004. PubMed ID: 21520454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interim analysis in clinical trials: a methodological guide].
    Muñoz Navarro SR; Bangdiwala SI
    Rev Med Chil; 2000 Aug; 128(8):935-41. PubMed ID: 11129556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four problems with group sequential methods.
    Whitehead J
    Control Clin Trials; 1991 Apr; 12(2):340-4. PubMed ID: 1645644
    [No Abstract]   [Full Text] [Related]  

  • 18. Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment.
    Whitehead J; Matsushita T
    Stat Med; 2003 Mar; 22(5):677-87. PubMed ID: 12587099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.
    Heritier S; Lô SN; Morgan CC
    Stat Med; 2011 Jun; 30(13):1541-54. PubMed ID: 21432887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.
    Hemmings R; Day S
    Drug Saf; 2004; 27(1):1-6. PubMed ID: 14720083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.